National Health Investors Inc expected to post earnings of 68 cents a share - Earnings Preview

National Health Investors

16/02/2024 21:29

* National Health Investors Inc  NHI.N   NHI  is expected
to show
a rise in quarterly revenue when it reports  results on February
20 for the period ending December 31 2023
    * The Murfreesboro Tennessee-based  company is expected to
report
a 11.0% increase in revenue to $78.445 million from $70.67
million a year ago, according to the mean estimate from 4
analysts, based on LSEG data. (SAL is on Total Revenue basis)
    * ​LSEG's mean analyst estimate for National Health
Investors Inc
is for earnings of 68 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 7
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for National
Health
Investors Inc is $55.00​, above​ its last closing price
of $53.64. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  1.08        1.08       1.08      Met     0
 Jun. 30 2023  1.08        1.08       1.06      Missed  -2.3
 Mar. 31 2023  0.99        1.00       1.11      Beat    11.4​
 Dec. 31 2022  1.09        1.09       0.85      Missed  -22.2
 ​​Sep.        1.06        1.07       1.06      Missed  -0.6
 30 2022                                                
 Jun. 30 2022  1.21        1.21       1.26      Beat    4.4​
 Mar. 31 2022  1.13        1.10       1.10      Met     -0.2
 Dec. 31 2021  1.09        1.11       1.06      Missed  -4.7
 This summary was machine generated February 16 at 21:29 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)